Lack of association of Toll-like receptor 2 Arg753Gln with cutaneous leishmaniasis

Parasitology International

Volumn 59, Issue 3, 2010, Pages 466-468

  Ajdary, Soheila ^a   Ghamilouie, Mir Mostafa ^b   Alimohammadian, Mohammad Hossein ^a   Hosseini, Mansoureh ^a   Pakzad, Saeed Reza ^c  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

Leishmaniasis; Polymorphism; TLR

Indexed keywords

ARGININE; GLUTAMINE; TOLL LIKE RECEPTOR 2; TRYPTOPHAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LEISHMANIA MAJOR; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN LEISHMANIASIS;

EID: 77955310402     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2010.03.008     Document Type: Article

References (24)

1. Ajdary S., Riazi-Rad F., Alimohammadian M.H., Pakzad S.R. Immune response to Leishmania antigen in anthroponotic cutaneous leishmaniasis. J Infec 2009, 59:139-143.
2. Sacks D., Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev 2002, 2:845-857.
3. Laskay T., Diefenbach A., Rollinghoff M., Solbach W. Early parasite containment is decisive for resistance to Leishmania major infection. Eur J Immunol 1995, 25:2220-2227.
4. Barton G.M., Medzhitov R. Toll-like receptor signaling pathways. Science 2003, 300:1524-1525.
5. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999, 11:443-451. 1999.
6. Schwadner R., Dziarski R., Wesche H., Rothe M., Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J Biol Chem 1999, 274:17406-17409.
7. Underhill D.M., Ozinsky A., Smith K.D., Aderem A. Toll-like receptor 2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA 1999, 96:14459-14463.
8. Takeuchi O., Hoshino K., Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000, 165:5392-5396. 2000.
9. Echchannaoui H., Frei K., Schnell C., Leib S.L., Zimmerli W., Landmann R. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J Infc Dis 2002, 186:798-806.
10. Lorenz E., Mira J., Cornish K.L., Arbour N.C., Schwartz D.A. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000, 68:6398-6401.
11. Kang T.J., Chae G. Detection of Toll-like receptor 2 (TLR2) mutation in the lepramotous leprosy patients. FEMS Immunol Med Microbiol 2001, 31:53-58.
12. Bochud P.Y., Hawn T.R., Aderem A. Cutting edge: a toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol 2003, 170:3451-3454.
13. Berdeli A., Çelik H.A., Özyürek R., Doǧrusuz B., Aydin H.H. TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children. J Mol Med 2005, 83:535-541.
14. Ogus A.C., Yoldas B., Ozdemir T., Uguz A., Olcen S., Keser I., Coskun M., et al. The Arg753Gln polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 2004, 23:219-223. 2004.
15. Kang T.J., Chae G.T. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 2001, 31:53-58.
16. Ben-Ali M., Barbouche M.R., Bousnina S., Chabbou A., Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol 2004, 11:625-626.
17. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988, 16:1215.
18. Schroder N.W., Hermann C., Hamann L., Gobel U.B., Hartung T., Schumann R.R. High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J Mol Med 2003, 81:368-372. 2003.
19. Becker I., Salaiza N., Aguirre M., Delgado J., Carrillo-Carrasco N., Kobeh L.G., et al. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol Biochem Parasitol 2003, 130:65-74.
20. Flandin J.F., Chano F., Descoteaux A. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages. Eur J Immunol 2006, 36:411-420.
21. Zafra G., Florez O., Morillo C.A., Echeverria L.E., Martin J., Gonzalez C.I. Polymorphisms of toll-like receptor 2 and 4 genes in Chagas disease. Mem Inst Oswaldo Cruz 2008, 103:27-30.
22. Campos M.A., CLosel M., Valente E.P., Cardoso J.E., Akira S., Alvarez-Leite J.I., et al. Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88. J Immunol 2004, 172:1711-1718.
23. von Aulock S., Schroder N.W.J., Traub S., Gueinzius K., Lorenz E., Hartung T., et al. Heterozygous Toll-like receptor 2 polymorphism does not affect lipoteichoic acid-induced chemokine and inflammatory responses. Infect Immun 2004, 72:1828-1831.
24. Düzgün N., Duman T., Haydardedeoǧlu F.E., Tutkak H. The lack of genetic association of the Toll-like receptor 2 (TLR2) Arg753Gln and Arg677Trp polymorphisms with rheumatic heart disease. Clin Rheumatol 2007, 26:915-919.